RIFAXIMIN IMPROVES DRIVING SIMULATOR PERFORMANCE IN MINIMAL HEPATIC ENCEPHALOPATHY: A DOUBLE-BLIND, PLACEBO-CONTROLLED, PROSPECTIVE RANDOMIZED TRIAL

被引：0
|
作者：
Bajaj, Jasmohan S. [1 ,2 ]
Heuman, Douglas M. [1 ,2 ]
Saeian, Kia [3 ]
Hafeezullah, Muhammad [3 ]
Bell, Debulon E. [1 ,2 ]
Sterling, Richard K. [1 ,2 ]
Stravitz, R. Todd [1 ,2 ]
Wegelin, Jacob A. [1 ]
White, Melanie [1 ,2 ]
Sanyal, Arun J. [1 ,2 ]
机构：
[1] Virginia Commonwealth Univ, Richmond, VA USA
[2] McGuire VA Med Ctr, Richmond, VA USA
[3] Med Coll Wisconsin, Milwaukee, WI 53226 USA
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
22
引用
收藏
页码：330A / 330A
页数：1
相关论文
共 50 条
  • [1] Rifaximin Improves Driving Simulator Performance in a Randomized Trial of Patients With Minimal Hepatic Encephalopathy
    Bajaj, Jasmohan S.
    Heuman, Douglas M.
    Wade, James B.
    Gibson, Douglas P.
    Saeian, Kia
    Wegelin, Jacob A.
    Hafeezullah, Muhammad
    Bell, Debulon E.
    Sterling, Richard K.
    Stravitz, R. Todd
    Fuchs, Michael
    Luketic, Velimir
    Sanyal, Arun J.
    [J]. GASTROENTEROLOGY, 2011, 140 (02) : 478 - U179
  • [2] Rifaximin Improves Cognitive Functions and Health-Related Quality of Life in Patients With Minimal Hepatic Encephalopathy: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial (The RIME Trial)
    Sidhu, Sandeep
    Goyal, Omesh
    Mishra, Bholeshwar P.
    Sood, Ajit
    Chhina, Rajoo S.
    Soni, Ravinder K.
    [J]. GASTROENTEROLOGY, 2010, 139 (01) : E18 - E19
  • [3] The role of probiotics in the treatment of minimal hepatic encephalopathy. A prospective, randomized, placebo-controlled, double-blind study
    Vlachogiannakos, Jiannis
    Vasianopoulou, Panayota
    Viazis, Nikos
    Chroni, Matilda
    Voulgaris, Theodoros
    Ladas, Spiros D.
    Karamanolis, Dimitrios G.
    [J]. HEPATOLOGY, 2014, 60 : 376A - 376A
  • [4] Cannabis smoking impairs driving performance on the simulator and real driving: a randomized, double-blind, placebo-controlled, crossover trial
    Micallef, Joelle
    Dupouey, Julien
    Jouve, Elisabeth
    Truillet, Romain
    Lacarelle, Bruno
    Taillard, Jacques
    Daurat, Agnes
    Authie, Colas
    Blin, Olivier
    Rascol, Olivier
    Philip, Pierre
    Mestre, Daniel
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 (05) : 558 - 570
  • [5] A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea
    DuPont, HL
    Jiang, ZD
    Okhuysen, PC
    Ericsson, CD
    de la Cabada, FJ
    Ke, S
    DuPont, MW
    Martinez-Sandoval, F
    [J]. ANNALS OF INTERNAL MEDICINE, 2005, 142 (10) : 805 - 812
  • [6] Rifaximin for the treatment of functional dyspepsia: a double-blind randomized placebo-controlled trial
    Tan, V.
    Liu, K.
    Lam, F.
    Hung, I.
    Yuen, M.
    Leung, W.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 154 - 154
  • [7] REVERSAL OF MINIMAL HEPATIC ENCEPHALOPATHY AFTER A PROBIOTIC ADMINISTRATION. A PROSPECTIVE, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY
    Vlachogiannakos, J.
    Vasianopoulou, P.
    Viazis, N.
    Chroni, M.
    Karamanolis, D.
    Ladas, S. D.
    [J]. JOURNAL OF HEPATOLOGY, 2016, 64 : S165 - S165
  • [8] Oral l-ornithine-l-aspartate in minimal hepatic encephalopathy: A randomized, double-blind, placebo-controlled trial
    Alvares-da-Silva, Mario Reis
    de Araujo, Alexandre
    Vicenzi, Joao Reinhardt
    da Silva, Gabriel Veber
    Oliveira, Fabiana Bazanella
    Schacher, Fernando
    Oliboni, Lucas
    Magnus, Aline
    Kruel, Leticia Pinto
    Prieb, Rita
    Teixeira Fernandes, Luiz Nelson
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (09) : 956 - 963
  • [9] A double-blind randomized placebo-controlled trial of albumin in outpatients with hepatic encephalopathy: HEAL study
    Fagan, Andrew
    Gavis, Edith A.
    Gallagher, Mary Leslie
    Mousel, Travis
    Davis, Brian
    Puri, Puneet
    Sterling, Richard K.
    Luketic, Velimir A.
    Lee, Hannah
    Matherly, Scott C.
    Sanyal, Arun J.
    Stravitz, R. Todd
    Patel, Vaishali
    Siddiqui, Mohammad S.
    Asgharpour, Amon
    Fuchs, Michael
    Thacker, Leroy
    Bajaj, Jasmohan S.
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 (02) : 312 - 321
  • [10] A randomized double-blind placebo-controlled trial of rifaximin in patients with abdominal bloating and flatulence
    Sharara, AI
    Aoun, E
    Abdul-Baki, H
    Mounzer, R
    Sidani, S
    ElHajj, I
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02): : 326 - 333
12345